Phio Pharmaceuticals Corpis A Clinical Stage Biotechnology Company Based In Marlboroughmassachusettsit Specializes In Rna Interferencernaitherapeuticsutilizing Its Proprietary Intasyla C Self Delivering Rnai Technology Platform To Improve Immune Cell Efficacy Against Cancerthe Company Focuses On Developing Precision Oncology Treatmentsparticularly For Various Forms Of Skin Cancer And Melanoma Phio S Pipeline Includes Ph 762Which Targets Cutaneous Squamous Cell Carcinomastage Iv Melanomaand Merkel Cell Carcinomaand Ph 894Aimed At Stage Iv Melanomahead And Neck Squamous Cell Carcinomahepatocellular Carcinomaand Hpv Related Cutaneous Squamous Cell Carcinomathe Company Collaborates With Academic Institutionsbiotech Firmsand Multinational Organizations To Advance Its Therapeutic Development And Supports Clinical Trialsincluding A Phase 1B Trial For Ph 762Phio Is Committed To Enhancing Drug Safety And Efficacy Through Translational Researchaiming To Create New Pathways Toward A Cancer Free Future
No conferences found for this company.
| Company Name | Rxi Pharmaceuticals Corporation |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
